Tumor necrosis factor-alpha mediates the proliferation of rat C6 glioma cells via beta-adrenergic receptors

J Neuroimmunol. 2005 Sep;166(1-2):102-12. doi: 10.1016/j.jneuroim.2005.05.011.

Abstract

In the present study, we observed that isoproterenol, a beta-adrenergic receptor (beta-AR) agonist, stimulated rat C6 glioma cell proliferation, while propranolol, a beta-AR blocker, greatly reduced the proliferative effect of TNF-alpha on C6 cells. The gene and protein expressions of both beta1- and beta2-ARs were enhanced in C6 cells after TNF-alpha treatment, and the increase in beta-AR was due to an increased number of binding sites and not due to increase in receptor affinity. We further showed that protein kinase C (PKC) was involved in the TNF-alpha-induced beta-AR expression. Collectively, our results indicate that TNF-alpha-induced proliferation in C6 glioma cells might be via the induction and activation of beta-ARs.

MeSH terms

  • Adrenergic beta-Antagonists / metabolism
  • Animals
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Dihydroalprenolol / metabolism
  • Glioma / metabolism*
  • Glioma / pathology*
  • Protein Kinase C / physiology
  • RNA, Messenger / metabolism
  • Rats
  • Receptors, Adrenergic, beta-1 / genetics
  • Receptors, Adrenergic, beta-1 / metabolism
  • Receptors, Adrenergic, beta-1 / physiology*
  • Receptors, Adrenergic, beta-2 / genetics
  • Receptors, Adrenergic, beta-2 / metabolism
  • Receptors, Adrenergic, beta-2 / physiology*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Adrenergic beta-Antagonists
  • RNA, Messenger
  • Receptors, Adrenergic, beta-1
  • Receptors, Adrenergic, beta-2
  • Tumor Necrosis Factor-alpha
  • Dihydroalprenolol
  • Protein Kinase C